Live Analyst Rating Changes 39633 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Graig Suvannavejh
MIZU

Graig Suvannavejh

Mizuho Securities
Wall Street Analyst
★★☆☆☆
#2635
on 13Foresight · ranked by our own returns
46%
Success Rate
-2.3%
Average Return
63 of 137 calls profitable · -131.7% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 46% of Graig Suvannavejh's ratings turned a profit when each position was held for 1 year — averaging -2.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

258 Buy 32 Hold 1 Sell
Graig's Stock Coverage 59 ratings · 2026-10-09
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ALEC
Alector
 Oct 06, 2026 HOLD Buy
+396.5% avg upside
15 analysts
$1.50
25.75% Downside
 · ·
RGNX
RegenXBio
 Oct 05, 2026 BUY Strong Buy
+355.5% avg upside
23 analysts
$22.00
171.87% Upside
 · ·
INSM
Insmed
 Oct 05, 2026 BUY Strong Buy
+69.8% avg upside
37 analysts
$195.00
93.98% Upside
 +1.4% ·
IMRX
Immuneering
 Oct 02, 2026 BUY Strong Buy
+378.7% avg upside
12 analysts
$12.00
220.80% Upside
 -3.2% ·
IMMX
Immix Biopharma
 Sep 30, 2026 BUY Strong Buy
+133.3% avg upside
9 analysts
$26.00
179.95% Upside
 -10.7% ·
HRMY
Harmony Biosciences Holdings
 Sep 25, 2026 BUY Strong Buy
+24.4% avg upside
14 analysts
$51.00
28.83% Upside
 -3.9% ·
LONA
LeonaBio
 Sep 23, 2026 BUY Buy
+86.4% avg upside
9 analysts
$15.00
160.91% Upside
 -1.0% ·
ALKS
Alkermes
 Sep 22, 2026 BUY Buy
+8.7% avg upside
34 analysts
$65.00
62.09% Upside
 -7.3% ·
CRBP
Corbus Pharmaceuticals
 Sep 14, 2026 BUY Strong Buy
+554.1% avg upside
20 analysts
$33.00
526.18% Upside
 -24.1% ·
AXSM
Axsome Therapeutics
 Sep 11, 2026 BUY Strong Buy
+39.3% avg upside
30 analysts
$316.00
85.88% Upside
 -23.0% ·
PVLA
Palvella Therapeutics
 Sep 10, 2026 BUY Strong Buy
+26.3% avg upside
27 analysts
$240.00
82.68% Upside
 -13.2% ·
BLTE
Belite Bio, Inc. ADR
 Sep 09, 2026 BUY Strong Buy
+31.6% avg upside
11 analysts
$234.00
53.51% Upside
 -13.1% ·
IDYA
IDEAYA Biosciences
 Sep 01, 2026 BUY Strong Buy
+33.5% avg upside
29 analysts
$50.00
38.62% Upside
 -6.5% ·
IMTX
Immatics
 Aug 20, 2026 BUY Strong Buy
+146.5% avg upside
15 analysts
$25.00
239.27% Upside
 -13.8% ·
AMLX
Amylyx Pharmaceuticals Inc
 Aug 19, 2026 BUY Strong Buy
+36.7% avg upside
14 analysts
$42.00
54.42% Upside
 -28.0% ·
NMRA
Neumora Therapeutics, Inc.
 Aug 17, 2026 BUY Buy
+1491.7% avg upside
11 analysts
$4.00
733.69% Upside
 -67.1% ·
EYPT
EyePoint Pharmaceuticals
 Aug 17, 2026 BUY Strong Buy
+560.2% avg upside
21 analysts
$39.00
1027.21% Upside
 -31.8% ·
CRVS
Corvus Pharmaceuticals
 Aug 11, 2026 BUY Strong Buy
+150.8% avg upside
14 analysts
$30.00
193.83% Upside
 -27.1% ·
TARS
Tarsus Pharmaceuticals
 Aug 11, 2026 BUY Strong Buy
+14.0% avg upside
17 analysts
$100.00
38.50% Upside
 +7.2% ·
ZNTL
Zentalis Pharmaceuticals
 Aug 11, 2026 BUY Strong Buy
+434.5% avg upside
20 analysts
$8.00
218.71% Upside
 -35.0% ·
VSTM
Verastem
 Aug 10, 2026 BUY Strong Buy
+91.8% avg upside
24 analysts
$13.00
60.39% Upside
 +21.7% ·
IMCR
Immunocore Holdings
 Aug 07, 2026 HOLD Strong Buy
+120.8% avg upside
22 analysts
$35.00
20.34% Upside
 -13.0% ·
ERAS
Erasca
 Dec 09, 2025 BUY Strong Buy
+35.4% avg upside
14 analysts
$5.00
67.75% Downside
 +327.9% ·
KALA
KALA BIO
 Oct 02, 2025 HOLD Strong Buy
+66599.7% avg upside
9 analysts
$75.00
25186.67% Upside
 · ·
BTAIQ
Bioxcel Therapeutics
 Sep 16, 2025 HOLD Strong Buy
+50521.1% avg upside
12 analysts
$4.00
8259.51% Upside
 · ·
ADAPY
Adaptimmune Therapeutics
 Aug 26, 2025 HOLD Buy
+8005.4% avg upside
10 analysts
 — -55.2% ·
GB:0QW0
arGEN X
 Jun 10, 2022 BUY Strong Buy
-19.2% avg upside
25 analysts
$400.00
46.53% Downside
 +17.6% ·
GB:0MGB
Genmab A/S
 May 05, 2022 HOLD Buy
-10.4% avg upside
25 analysts
$2754.00
17.12% Upside
 +23.7% ·
CH:IDIA
Idorsia Ltd
 May 05, 2022 HOLD Sell
+4.8% avg upside
9 analysts
$17.00
319.66% Upside
 -44.2% ·
IT:PHIL
Philogen SpA
 May 05, 2022 HOLD Hold
-14.1% avg upside
2 analysts
$16.50
24.41% Downside
 +10.0% ·
HALO
Halozyme
 Nov 15, 2021 BUY Strong Buy
-40.3% avg upside
20 analysts
$50.00
54.47% Downside
 +41.4% ·
AUTL
Autolus Therapeutics
 Nov 09, 2021 HOLD Strong Buy
+497.5% avg upside
16 analysts
$6.50
267.16% Upside
 -70.6% ·
FR:DBV
DBV Technologies
 Oct 28, 2021 BUY Hold
+207.2% avg upside
3 analysts
$6.00
255.25% Upside
 -46.3% ·
NL:LKFT
Lakefront Biotherapeutics NV
 Oct 05, 2021 SELL Sell
+94.8% avg upside
17 analysts
$44.00
70.02% Upside
 -4.1% ·
FR:VLA
Valneva
 Sep 21, 2021 BUY Strong Buy
+259.5% avg upside
3 analysts
$14.50
483.51% Upside
 -54.9% ·
RYTM
Rhythm Pharmaceuticals
 Aug 04, 2021 SELL Strong Buy
+37.7% avg upside
22 analysts
$16.00
82.22% Downside
 -33.9% ·
CYTK
Cytokinetics
 Jul 20, 2021 HOLD Strong Buy
+46.4% avg upside
36 analysts
$26.00
57.98% Downside
 +33.1% ·
FR:IPH
Innate Pharma SA
 Jun 29, 2021 HOLD Strong Buy
+585.3% avg upside
5 analysts
$3.50
176.37% Upside
 -5.2% ·
KOD
Kodiak Sciences
 May 14, 2021 HOLD Buy
-20.3% avg upside
12 analysts
$96.00
1.78% Upside
 -93.4% ·
ZLDPF
Zealand Pharma
 May 13, 2021 BUY Strong Buy
+115.1% avg upside
12 analysts
$33.80
9.98% Downside
 -65.8% ·
DSGN
Design Therapeutics
 Apr 20, 2021 HOLD Strong Buy
+54.0% avg upside
9 analysts
$28.00
143.70% Upside
 -30.9% ·
EWTX
Edgewise Therapeutics
 Apr 19, 2021 HOLD Strong Buy
+15.8% avg upside
15 analysts
$31.00
20.92% Downside
 -70.7% ·
IRON
Disc Medicine
 Mar 02, 2021 BUY Strong Buy
+45.3% avg upside
21 analysts
$20.00
67.07% Downside
 -91.3% ·
ARQT
Arcutis Biotherapeutics
 Feb 03, 2021 BUY Strong Buy
+65.4% avg upside
14 analysts
$55.00
124.52% Upside
 -57.6% ·
DBVT
DBV Technologies SA - American
 Jan 15, 2021 BUY Strong Buy
+150.9% avg upside
15 analysts
$7.00
26.70% Downside
 -71.0% ·
LKFT
Lakefront Biotherapeutics
 Dec 21, 2020 SELL Buy
+245.8% avg upside
25 analysts
$90.00
204.97% Upside
 +42.3% ·
IPHA
Innate Pharma
 Nov 23, 2020 HOLD Strong Buy
+368.0% avg upside
10 analysts
$4.75
221.03% Upside
 -3.8% ·
JAZZ
Jazz Pharmaceuticals
 Nov 11, 2020 SELL Strong Buy
+12.8% avg upside
36 analysts
$145.00
34.80% Downside
 +8.2% ·
PRLD
Prelude Therapeutics
 Oct 20, 2020 HOLD Buy
+179.5% avg upside
7 analysts
$37.00
853.71% Upside
 -38.1% ·
BCYC
Bicycle Therapeutics
 May 11, 2020 BUY Buy
+535.1% avg upside
21 analysts
$19.00
398.79% Upside
 +105.0% ·
KRYS
Krystal Biotech
 Sep 24, 2019 HOLD Strong Buy
-14.4% avg upside
20 analysts
$60.00
81.62% Downside
 +0.4% ·
ARGX
Argenx Se
 Dec 17, 2018 BUY Strong Buy
-0.2% avg upside
48 analysts
$154.00
81.25% Downside
 +58.3% ·
TGTX
TG Therapeutics
 Sep 23, 2014 BUY Strong Buy
-17.2% avg upside
20 analysts
$16.00
69.98% Downside
 -0.2% ·
MNKD
MannKind
 Jul 01, 2014 HOLD Buy
+105.4% avg upside
22 analysts
$11.00
221.71% Upside
 -45.9% ·
ACUR
Acura Pharmaceuticals
 May 28, 2014 HOLD Strong Buy
+2970197.0% avg upside
2 analysts
$1.00
989999.01% Upside
 · ·
ATHE
Alterity Therapeutics
 Apr 01, 2014 HOLD Strong Buy
+224.9% avg upside
8 analysts
$3.00
2.37% Downside
 · ·
LGND
Ligand Pharma
 Feb 13, 2014 BUY Strong Buy
-6.5% avg upside
16 analysts
$96.00
67.54% Downside
 -29.4% ·
ORMP
Oramed Pharm
 Feb 03, 2014 BUY Strong Buy
+356.1% avg upside
7 analysts
$27.00
542.80% Upside
 -71.6% ·
FBIO
Fortress Biotech
 Oct 15, 2013 HOLD Strong Buy
+277.3% avg upside
12 analysts
$2.00
4.22% Downside
 +7.0% ·
🔒 54 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Graig Suvannavejh — Frequently Asked Questions
How accurate are Graig Suvannavejh's stock ratings?
Based on the calls 13Foresight could measure, about 46% of Graig's ratings were profitable over a one-year hold, with an average return of -2.1% per rating, or -132.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Graig ranked on 13Foresight?
Graig Suvannavejh is currently ranked #2635 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Graig cover?
Graig most recently has ratings on ALEC, RGNX, INSM, IMRX, IMMX, HRMY, LONA, ALKS, CRBP, AXSM, PVLA, BLTE and 47 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.